Hisamitsu Pharmaceutical Co., Inc.
$29.00+0.00%(+$0.00)
TickerSpark Score
68/100
84
Valuation
85
Profitability
25
Growth
84
Health
60
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HTSUF research report →
52-Week Range2% of range
Low $28.94
Current $29.00
High $32.30
Companywww.hisamitsu.co.jp
Hisamitsu Pharmaceutical Co. , Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan.
- CEO
- Kazuhide Nakatomi
- IPO
- 2010
- Employees
- 2,759
- HQ
- Tosu, JP
Price Chart
-10.22% · this period
Valuation
- Market Cap
- $2.04B
- P/E
- 22.30
- P/S
- 2.61
- P/B
- 1.46
- EV/EBITDA
- 13.58
- Div Yield
- 1.99%
Profitability
- Gross Margin
- 58.96%
- Op Margin
- 10.99%
- Net Margin
- 11.75%
- ROE
- 6.99%
- ROIC
- 4.66%
Growth & Income
- Revenue
- $163.49B · 4.80%
- Net Income
- $19.22B · -11.68%
- EPS
- $269.27 · -8.90%
- Op Income
- $17.97B
- FCF YoY
- 90.55%
Performance & Tape
- 52W High
- $32.30
- 52W Low
- $28.94
- 50D MA
- $29.00
- 200D MA
- $29.00
- Beta
- 0.29
- Avg Volume
- 46.285
Get TickerSpark's AI analysis on HTSUF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HTSUF Coverage
We haven't published any research on HTSUF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HTSUF Report →Similar Companies
DMPHF+0.00%
Dermapharm Holding SE
$39.56
TSMRF+0.00%
Tsumura & Co.
$23.20
CHSYF+0.00%
China Medical System Holdings Limited
$1.35
SHPHF+0.00%
Sihuan Pharmaceutical Holdings Group Ltd.
$0.19
CURLF+3.42%
Curaleaf Holdings, Inc.
$3.33
ARSUF+0.00%
Fagron N.V.
$26.53
LBTSF-0.78%
Almirall, S.A.
$15.35
CASBF+0.00%
CanSino Biologics Inc.
$3.89